Algorithm for Sequencing Glucose-Lowering Therapies in Type 2 Diabetes
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
- About 29.1 million people or 9.3% of the US population had diabetes in 2012. Of these, approximately 8.1 million or 27.8% had undiagnosed diabetes.
- Glycemic management in type 2 diabetes is complex and evolving, with many new therapies for type 2 diabetes having been introduced over the past few years.
- More recent guidelines emphasize a patient-centered approach and also take into consideration patient factors when choosing therapies and appropriate glycemic goals (i.e. patient involvement and expected efforts, comorbidities especially established vascular complications, disease duration, life expectancy).
- Other factors to consider when choosing therapies for type 2 diabetes might include: efficacy, cost, available resources and support system, fasting versus postprandial hyperglycemia, risk of hypoglycemia, weight changes, drug side effects, route of administration, drug’s mechanism of action.